This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides The FDA just made a move that changes everything for my patients. For nearly two years, some of the most clinically promising peptides in longevity and autoimmune medicine were locked away AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism FDA Peptide Update What You Need to Know Big shift this week. The FDA is actively updating its peptide policy, with multiple compounds moving out of Category 2 and into formal BREAKING: The FDA just reversed their 2023 peptide ban. 12 peptides pulled from the Category 2 restricted list: 1. BPC 157 2. Thymosin beta 4 fragment (TB 500) 3. Epitalon 4. GHK Cu 5. MOTS C 6.